Publications by authors named "Gert Hoeffken"

Claim this Profile
6
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.
Wolfgang Schuette, Claus-Peter Schneider, Walburga Engel-Riedel, Christian Schumann, Martin Kohlhaeufl, Gert Hoeffken

Lung Cancer (Auckl)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study].
David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, Matthias Feurer, Achim Rittmeyer

Dtsch Med Wochenschr· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemoptysis due to pulmonary venous stenosis.
Silke Braun, Ivan Platzek, Klaus Zöphel, Matthias Weise, Martin Kolditz, Gert Hoeffken

Eur Respir Rev· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.
Dirk Steffen Koschel, Martin Kolditz, Gert Höeffken, Michael Halank

Med Sci Monit· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portopulmonary hypertension.
Michael Halank, Ralf Ewert, Hans-Juergen Seyfarth, Gert Hoeffken

J Gastroenterol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
Michael Halank, Martin Kolditz, Christian Opitz, Gert Hoeffken, Ralf Ewert

Wien Klin Wochenschr· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
Michael Halank, Martin Kolditz, Stephan Miehlke, Steffen Schiemanck, Alexander Schmeisser, Gert Hoeffken

Wien Med Wochenschr· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.
Michael Halank, Christian Marx, Stephan Miehlke, Gert Hoeffken

J Gastroenterol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.
Michael Halank, Stephan Miehlke, Gert Hoeffken, Alexander Schmeisser, Matthias Schulze

Transplantation· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies.
Frank Kroschinsky, Matthias Weise, Thomas Illmer, Mathias Haenel, Martin Bornhaeuser, Gert Hoeffken

Intensive Care Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis